Epidermal Nerve Fiber Density Testing
Customize your policy alerts
Sign up for select_health Policy CCP.1263 alerts
Get alerted when Policy CCP.1263 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and coverage stance for epidermal (intraepidermal) nerve fiber density testing by skin punch biopsy to detect small fiber neuropathy for Select Health of South Carolina members.
No material clinical or coverage changes in this revision.
Coverage Criteria for Epidermal Nerve Fiber Density Testing
Medical necessity criteria
Covered when ALL of the following are met
supported by AANEM and joint guideline statements
policy requires absence of known predisposing disorder
both exam and electrodiagnostic testing must show no large-fiber involvement
Epidermal (intraepidermal) nerve fiber density testing by skin biopsy is covered only when the specific clinical criteria in this policy are met. All other uses of epidermal nerve fiber density testing are investigational/not clinically proven and therefore not medically necessary.
Any indication that does not meet the policy’s required medical necessity criteria — including use of the test to distinguish disease etiology, to assess prognosis, or for routine monitoring when not otherwise supported — is considered investigational or not medically necessary under this policy.
Related Codes
| 88356 | Morphometric analysis; nerve |
Provider Actions, Documentation, and Billing Notes
Prior authorization / coding note: submit supporting documentation and code 88356
Coverage applies only when all clinical criteria are met. When submitting claims, include supporting documentation that demonstrates the member meets the policy criteria and attach the commonly submitted procedure code 88356 where appropriate.
- Include documentation that the member presents with symptoms of painful sensory neuropathy.
- Include evidence that the member has no history of a disorder known to predispose to painful neuropathy.
- Include results showing no large-fiber neuropathy on both physical exam and electromyography/nerve-conduction studies.
Alternatives to biopsy: consider noninvasive and diagnostic testing first
Consider alternative covered services before or in addition to biopsy, including neurologic consultation and targeted diagnostic testing to screen for treatable causes of small fiber neuropathy.
- Neurologic consultation
- Screening for other treatable causes of small fiber neuropathy
- Functional tests (e.g., quantitative sensory testing)
- Autonomic testing
- Nerve conduction testing; somatosensory evoked potentials; nerve biopsy
Required clinical documentation to support medical necessity
Documentation must demonstrate the presence of painful sensory neuropathy symptoms, absence of disorders known to predispose to painful neuropathy, and absence of large-fiber neuropathy on both physical examination and electrodiagnostic testing.
- Record of symptoms consistent with painful sensory neuropathy.
- Medical history showing no disorder known to predispose to painful neuropathy (e.g., diabetes).
- Physical exam findings excluding large-fiber involvement (e.g., preserved reflexes, proprioception, vibration).
- Electromyography and nerve-conduction study results showing no large-fiber neuropathy.
- Laboratory testing and biopsy technique/normative ranges as appropriate.
Denial triggers: missing criteria or contraindicating findings
Requests lacking any of the required clinical criteria are at risk for denial, including absence of painful sensory neuropathy symptoms, presence of a disorder known to predispose to painful neuropathy, or evidence of large-fiber neuropathy on exam or electrodiagnostic testing.
- No documented symptoms of painful sensory neuropathy.
- History of a disorder known to predispose to painful neuropathy (e.g., diabetic neuropathy).
- Evidence of large-fiber neuropathy on physical examination (reduced/absent reflexes or reduced proprioception/vibration).
- Electromyography or nerve-conduction studies showing large-fiber involvement.
Background
Small fiber neuropathy is a peripheral nerve disorder that selectively affects small-diameter myelinated and unmyelinated nerve fibers and commonly presents with variable sensory symptoms such as pain, burning, or altered sensation. Etiologies include genetic mutations, diabetes, autoimmune disease, infections, toxins, and idiopathic causes. Epidermal nerve fiber density testing quantifies intraepidermal nerve fibers per millimeter using a skin punch biopsy and immunostaining to assess the structural integrity of small nerve fibers; normative values vary by biopsy site, technique, age, and gender, and results are interpreted in the context of clinical and electrodiagnostic findings.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.